Publication | Closed Access

Safety and activity of pembrolizumab in patients with locally advanced or metastatic urothelial cancer (KEYNOTE-012): a non-randomised, open-label, phase 1b study

Metastatic Urothelial CancerUrologyGenitourinary CancerMedicineImmune Checkpoint InhibitorCancer TreatmentOncologyRadiation Oncology